Phage Therapy Revival
Samuel Livingston
Translator A AI
Publisher: Publifye
Summary
Phage Therapy Revival explores the resurgence of bacteriophage therapy as a potent weapon against bacterial infections, especially in the face of growing antibiotic resistance. This approach uses viruses, known as bacteriophages, to selectively target and destroy bacteria, offering a personalized and adaptable alternative to traditional antibiotics. The book highlights the increasing threat posed by antibiotic-resistant bacteria, which render common infections untreatable, and emphasizes how phage therapy can evolve alongside bacteria, providing a sustainable solution. The book traces the history of phage therapy from its early 20th-century origins to its decline in the West and continued development in Eastern Europe. It delves into the basic principles of microbiology and virology, explaining how bacteriophages infect and kill bacteria without harming human cells. Readers will understand that while antibiotics can wipe out both harmful and beneficial bacteria, phages target specific bacterial strains, minimizing disruption to the body's natural microbiome. The book progresses from introducing antibiotic resistance and bacteriophage biology to discussing phage isolation, clinical trials, regulatory challenges, and future directions, including personalized treatments. Ultimately, Phage Therapy Revival argues that phage therapy, while not a cure-all, is a crucial tool in combating bacterial infections. It emphasizes the need for further research, streamlined regulatory pathways, and increased awareness among healthcare professionals to fully realize the potential of this promising antimicrobial therapy. The book provides a comprehensive yet accessible overview, bridging the gap between complex scientific concepts and practical applications, making it valuable for students, researchers, and anyone interested in the future of antimicrobial therapy.
Available since: 02/27/2025.
Print length: 86 pages.
